Malaysian Journal of Pathology, published by the MALAYSIAN JOURNAL PATHOLOGY, stands as a pivotal resource in the fields of pathology and medicine, contributing rich insights since its inception in 1979. This peer-reviewed journal, based in Malaysia, is dedicated to disseminating original research, review articles, and case studies that advance the understanding of disease mechanisms and diagnostics. With a current impact factor reflecting its ranked positioning—Q4 in Cell Biology, Q4 in Histology, and Q3 in both Miscellaneous Medicine and Pathology & Forensic Medicine—this journal serves as an essential platform for researchers, clinicians, and students alike. Although it operates without open access, its scholarly rigor and contributions are well recognized, holding ranks such as #84 in Pathology and Forensic Medicine according to Scopus. The Malaysian Journal of Pathology is committed to fostering innovation and excellence in medical research, making it an invaluable tool for professionals seeking to stay abreast of significant advancements in the pathology domain.

EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.

The Journal of Pathology Clinical Research is a prestigious academic platform published by WILEY, dedicated to advancing the field of pathology and forensic medicine. Since its inception in 2015, this Open Access journal has championed the dissemination of cutting-edge research relevant to both clinical practice and laboratory science, allowing for greater visibility and accessibility to researchers, professionals, and students worldwide. With a robust Q1 ranking in the Pathology and Forensic Medicine category for 2023, it stands as a critical resource for those seeking to stay at the forefront of the field, currently positioned at rank #29 out of 208 according to Scopus metrics, placing it in the 86th percentile. The journal's commitment to high-quality peer-reviewed articles fosters an environment of scholarly exchange that is essential for innovation and professional growth in pathology and forensic studies. Researchers and practitioners alike are encouraged to contribute and engage with a community dedicated to excellence in clinical research.

AJSP-Reviews and Reports is a peer-reviewed journal dedicated to the advancement of knowledge within the field of pathology and forensic medicine. Published by the renowned Lippincott Williams & Wilkins, this journal plays a vital role in disseminating insightful reviews and reports that contribute to the understanding and application of diagnostic practices and forensic investigations. While currently listed in the fourth quartile (Q4) within its category according to the 2023 metrics, the journal is committed to enhancing its impact and fostering scholarly dialogue among researchers, professionals, and students in the medical community. Despite challenges in Scopus rankings, it provides a platform for significant discourse and innovation in pathology. Operating from the United Kingdom, AJSP-Reviews and Reports is positioned to bridge gaps in knowledge and inspire future research developments. Readers can access valuable findings without open access barriers, allowing for efficient information sharing within the medical field.

PATHOLOGICA is a leading academic journal dedicated to the field of pathology and forensic medicine, published by PACINI EDITORE. With a rich history dating back to its inception in 1945, the journal has consistently contributed to the advancement of knowledge in these vital areas of medical research and practice. Currently ranked in the Q1 quartile for Pathology and Forensic Medicine and holding an impressive position as #42 out of 208 in the Scopus rankings, it reflects a significant impact within the academic community, boasting an 80th percentile ranking. The journal is committed to publishing high-quality, peer-reviewed articles that explore innovative research findings and clinical advancements, making it an essential resource for researchers, clinicians, and students alike. Though it does not offer open access, PATHOLOGICA continues to foster scholarly communication by disseminating cutting-edge research findings, thus playing a pivotal role in enhancing pathology education and practice worldwide.

MODERN PATHOLOGY is a premier journal in the field of pathology and forensic medicine, published by Elsevier Science Inc. With an impressive impact factor that places it in the top 1st quartile (Q1) for 2023, and a remarkable rank of 5 out of 208 in its category according to Scopus, it serves as a vital resource for researchers, professionals, and students alike. Established in 1988, the journal focuses on the latest advancements in diagnostic pathology, molecular pathology, and related fields, providing a platform for innovative research that drives the discipline forward. Although it does not operate under an open access model, readers can expect rigorously peer-reviewed publications that contribute to the growing body of knowledge in pathology. With a continuous commitment to excellence and relevance, MODERN PATHOLOGY remains a fundamental avenue for disseminating high-quality scientific research globally, facilitating the growth and development of its field.

The Journal of Pathology and Translational Medicine, published by the Korean Society of Pathologists, is a distinguished peer-reviewed Open Access journal that has been at the forefront of advancing the field of pathology and histology since its inception in 1985. With an established ISSN of 2383-7837 and an E-ISSN of 2383-7845, the journal serves as a vital platform for disseminating high-quality research, fostering collaboration among professionals and offering valuable insights into both clinical applications and theoretical advancements. Recognized for its influence in the field, it holds a commendable Q2 ranking in both Histology and Pathology & Forensic Medicine categories in 2023, and ranks #52/208 in Scopus for Medicine – Pathology and Forensic Medicine, demonstrating its impact and reach within the academic community. Located in South Korea at 1209 Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, this journal not only caters to researchers and professionals but also supports students striving to deepen their understanding of pathology. Join the growing body of knowledge and stay updated with the latest findings in this essential field of study through the journal's open access format, promoting worldwide accessibility and engagement.

HISTOPATHOLOGY is a premier scholarly journal published by WILEY, targeting the fields of histology, pathology, and forensic medicine. With an ISSN of 0309-0167 and an E-ISSN of 1365-2559, this esteemed journal has maintained a strong academic presence since its inception in 1977. Boasting an impressive Q1 ranking in crucial categories such as Histology and Pathology, it ranks 13th out of 208 in Pathology and Forensic Medicine, and 5th out of 62 in Histology, reflecting its high impact and relevance within the scientific community. HISTOPATHOLOGY serves as a critical platform for disseminating significant research findings, reviews, and advancements in the diagnostic and therapeutic aspects of pathology. Although it does not operate under an open access model, its rigorous peer-review process ensures that published articles uphold the highest standards of scientific integrity. Scholars and practitioners alike benefit from the insights shared in this journal, as it aims to bridge the gap between laboratory science and clinical practice, fostering innovation and enhancing our understanding of disease mechanisms.

Advances in Cancer Biology-Metastasis is an emerging journal published by Elsevier, aimed at advancing our understanding of the complexities of cancer biology, with a specific focus on the mechanisms and pathways related to metastasis. With an E-ISSN of 2667-3940, this journal offers a platform for researchers, professionals, and students in the fields of Cancer Research and Cell Biology to disseminate innovative findings and discuss novel therapeutic approaches. Though currently classified in the Q4 quartile across both Cancer Research and Cell Biology categories, the journal aspires to enhance its impact through rigorous peer review and high-quality publication. Positioned to cover the years from 2021 to 2024, it seeks to bridge gaps in foundational knowledge and promote collaborative research efforts that could pivot the current understanding of cancer metastasis. Researchers are encouraged to take advantage of this platform to advocate for advancements in cancer biology, making significant contributions that can influence both academic and clinical practices.

Pathologie is a distinguished academic journal published by Springer Heidelberg, dedicated to advancing the field of pathology and forensic medicine. With an ISSN of 2731-7188 and an E-ISSN of 2731-7196, this journal serves as a vital platform for researchers, professionals, and students to disseminate innovative findings and insights. Currently ranked in the Q3 category of pathology and forensic medicine according to the 2023 metrics, Pathologie reflects a commitment to quality and relevance in a dynamic research landscape. Despite its relatively recent establishment from 2022, the journal is gaining traction with a Scopus rank of 139 out of 208 in its category, positioning itself as an emerging resource within the academic community. While it operates under a subscription model, the importance of the journal lies in its objective to facilitate the exploration of diverse pathological processes and enhance forensic methodologies, ultimately improving clinical outcomes and investigative practices. As it continues to grow, Pathologie stands poised to impact the pathology domain significantly.